Jan 14, 2026 08:31AM
Jan 5, 2026 05:32AM
Dec 29, 2025 10:16AM
Nov 12, 2025 04:34PM
Oct 27, 2025 08:30AM
Oct 13, 2025 08:02AM
Oct 10, 2025 04:08PM SELLAS Life Sciences (SLS) files for 19.7M share offering by selling stockholders
Sep 11, 2025 08:31AM
Aug 12, 2025 05:40PM
Jul 7, 2025 08:45AM
Jun 24, 2025 08:00AM
Jun 5, 2025 08:45AM
Jun 2, 2025 08:01AM
May 15, 2025 08:45AM SELLAS Life Sciences (SLS) Announces First Pediatric AML Patient Dosed in the Ongoing Phase 2 Trial of SLS009 r/r AML
May 13, 2025 04:13PM
Apr 28, 2025 08:45AM
Apr 8, 2025 08:45AM
Feb 20, 2025 08:45AM
Jan 28, 2025 03:12PM
Jan 23, 2025 08:11AM
Jan 8, 2025 08:20AM SELLAS Life Sciences (SLS) Announces Key Business Objectives for 2025
Dec 10, 2024 08:32AM
Dec 9, 2024 08:45AM
Nov 27, 2024 08:46AM
Nov 13, 2024 05:51PM
Oct 15, 2024 08:45AM
Aug 13, 2024 05:11PM
Aug 6, 2024 08:45AM SELLAS Life Sciences (SLS) Receives EMA Orphan Drug Designation for SLS009
Jul 31, 2024 08:31AM
Jul 16, 2024 09:05AM
Jul 8, 2024 08:46AM
Jun 24, 2024 09:05AM
Jun 18, 2024 08:45AM
Jun 17, 2024 09:05AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All